A New Furoxan NO‐Donor Rabeprazole Derivative and Related Compounds
- 4 September 2003
- journal article
- Published by Wiley in ChemBioChem
- Vol. 4 (9) , 899-903
- https://doi.org/10.1002/cbic.200300617
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antiinflammatory, Gastrosparing, and Antiplatelet Properties of New NO-Donor Esters of AspirinJournal of Medicinal Chemistry, 2003
- Nitric oxide donor drugs: current status and future trendsExpert Opinion on Investigational Drugs, 2002
- RabeprazoleDrugs, 2001
- The control of gastric acid and Helicobacter pylori eradicationAlimentary Pharmacology & Therapeutics, 2000
- The proton-pump inhibitors: Similarities and differencesClinical Therapeutics, 2000
- Effect of Nitric Oxide onHelicobacter pyloriMorphologyThe Journal of Infectious Diseases, 1999
- Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the ratGeneral Pharmacology: The Vascular System, 1995
- The Pharmacology of the Gastric Acid Pump: The H+,K+ ATPaseAnnual Review of Pharmacology and Toxicology, 1995
- Helicobacter pylori Urease Inhibition by Rabeprazole, a Proton Pump Inhibitor.Biological & Pharmaceutical Bulletin, 1995
- The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugsTrends in Pharmacological Sciences, 1994